Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,776 | 2,503 | 679 | 1,390 | 2,390 |
| Marketable Securities | 304 | 189 | 178 | 174 | 272 |
| Receivables | 3,405 | 2,324 | 2,013 | 1,411 | 1,724 |
| Inventories | 399 | 404 | 241 | N/A | N/A |
| Other current assets | 1,494 | 527 | 492 | 744 | 884 |
| TOTAL | $13,506 | $6,704 | $4,184 | $4,218 | $5,808 |
| Non-Current Assets | |||||
| PPE Net | 6,451 | 4,398 | 5,141 | 8,029 | 11,963 |
| Intangibles | 7,669 | 8,290 | 498 | 0 | 0 |
| Other Non-Current Assets | 1,762 | 1,238 | 1,019 | 1,133 | 1,051 |
| TOTAL | $15,882 | $13,926 | $6,658 | $9,162 | $13,014 |
| Total Assets | $29,388 | $20,630 | $10,842 | $13,380 | $18,822 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 89 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,590 | 612 | 657 | 906 | 816 |
| Accrued Expenses | 2,207 | 3,174 | 1,177 | 933 | 1,408 |
| TOTAL | $6,862 | $5,939 | $3,620 | $4,178 | $4,915 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,000 | 2,250 | 2,479 | 3,919 |
| Deferred Revenues | 1,739 | 1,684 | 1,199 | 2,008 | 1,575 |
| Other Non-Current Liabilities | 0 | 184 | 2,640 | 2,825 | 4,019 |
| TOTAL | $491 | $1,627 | $5,742 | $6,291 | $9,825 |
| Total Liabilities | $7,353 | $7,566 | $9,362 | $10,469 | $14,740 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 1 | 1 | N/A |
| Common Shares | 264 | 242 | 196 | 192 | 179 |
| Retained earnings | -86,769 | -81,790 | -79,079 | -76,890 | -73,234 |
| Other shareholders' equity | -468 | -627 | -848 | -1,030 | -1,016 |
| TOTAL | $22,035 | $13,064 | $1,480 | $2,911 | $4,082 |
| Total Liabilities And Equity | $29,388 | $20,630 | $10,842 | $13,380 | $18,822 |